| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3361032 | International Journal of Antimicrobial Agents | 2007 | 5 Pages |
Abstract
Despite the availability of endocarditis prophylaxis guidelines for more than five decades, no prospective, randomised trial has ever been conducted to evaluate the efficacy and safety of this practice. This fact, in combination with mixed results from case-control investigations and other factors, has prompted a re-evaluation of the appropriateness of the guidelines. The update provided herein highlights recent revisions in guidelines promulgated by different countries.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Larry M. Baddour,